Risk of fracture in users of hormonal contraception

Ramanadhan S, Shaalini Ramanadhan, Jillian T Henderson, Henderson JT, Amy Cantor, Cantor A, Paynter RA, Robin A Paynter, Alison Edelman, Edelman A
The Cochrane database of systematic reviews · 2024 · vol. 10(10) , pp. CD015972 · doi:10.1002/14651858.cd015972 · PMID:39417291 · PMC11483432
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-29 ⓘ

This Cochrane protocol aims to assess the effects of hormonal contraception used for pregnancy prevention on fracture risk in individuals capable of becoming pregnant.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of hormonal contraception used for pregnancy prevention on fracture risk in individuals who are currently or were previously capable of becoming pregnant.

My notes (saved in your browser only)

MeSH descriptors

Fractures, Bone Fractures, Bone Fractures, Bone Contraceptives, Oral, Hormonal Contraceptives, Oral, Hormonal Female Hormonal Contraception Hormonal Contraception Humans Pregnancy Randomized Controlled Trials as Topic

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:46:11.266357+00:00
unpaywall
last seen: 2026-11-01T06:18:20.579057+00:00